New drug shows promise in preventing a serious transplant complication
NCT ID NCT02867384
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested whether a drug called obinutuzumab can prevent chronic graft-versus-host disease (cGVHD), a common and serious complication after a stem cell transplant. The trial involved 181 people who had received a stem cell transplant from a donor. The main goal was to see if obinutuzumab could reduce the need for steroids to treat cGVHD in the first year after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.